Abstract
It is established that the gut microbiota has a significant influence on Alzheimer’s disease. In turn, both the disease and the microbiota are affected by biological variables associated with modern lifestyles. Examination of the potential interrelationship among these three factors and on the role played by lifestyles in gut dysbiosis-induced pathologies of Alzheimer’s disease are limited. Deciphering these connections will provide insights into the pathogenesis and therapeutic strategies for Alzheimer’s disease. Specifically, based on this trilateral relationship, various nonpharmacological interventive strategies targeting the gut microbiota can be developed. This review fills this gap by presenting the latest evidence for the modulative role of modern lifestyle on the gut microbiota and its relevance to Alzheimer’s disease, with a discussion on the limitations of current research and future directions.
Keywords: Gut microbiota, Alzheimer's disease, modern lifestyle, dietary pattern, exercise, mental stress.
Graphical Abstract
Current Aging Science
Title:Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease
Volume: 14 Issue: 3
Author(s): Yi Wang*Gary Dykes
Affiliation:
- School of Agriculture and Food Sciences, University of Queensland, Keyhole Road, St Lucia, Queensland 4067,Australia
Keywords: Gut microbiota, Alzheimer's disease, modern lifestyle, dietary pattern, exercise, mental stress.
Abstract: It is established that the gut microbiota has a significant influence on Alzheimer’s disease. In turn, both the disease and the microbiota are affected by biological variables associated with modern lifestyles. Examination of the potential interrelationship among these three factors and on the role played by lifestyles in gut dysbiosis-induced pathologies of Alzheimer’s disease are limited. Deciphering these connections will provide insights into the pathogenesis and therapeutic strategies for Alzheimer’s disease. Specifically, based on this trilateral relationship, various nonpharmacological interventive strategies targeting the gut microbiota can be developed. This review fills this gap by presenting the latest evidence for the modulative role of modern lifestyle on the gut microbiota and its relevance to Alzheimer’s disease, with a discussion on the limitations of current research and future directions.
Export Options
About this article
Cite this article as:
Wang Yi *, Dykes Gary , Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease, Current Aging Science 2021; 14 (3) . https://dx.doi.org/10.2174/1874609814666210609100048
DOI https://dx.doi.org/10.2174/1874609814666210609100048 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Myeloperoxidase: The Good, the Bad, and the Ugly
Current Immunology Reviews (Discontinued) Effect of Oxidative Stress on the Pharmacokinetics of Clomipramine in Rats Treated with Ferric-Nitrilotriacetate
Drug Metabolism Letters Integrating Pharmacogenetics for Assessment of Herb-Drug Interactions: Has the Time Come?
Current Pharmacogenomics and Personalized Medicine Nanomedicine Against Malaria
Current Medicinal Chemistry Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Current Pharmaceutical Design Protein Arginine Methyltransferase 1 and its Dynamic Regulation Associated with Cellular Processes and Diseases
Protein & Peptide Letters Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Application of Decoy Oligodeoxynucleotides-Based Approach to Renal Diseases
Current Drug Targets Biologically Active Dietary Peptides
Mini-Reviews in Medicinal Chemistry Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety Role of PGE2 and EP Receptors in the Pathogenesis of Rheumatoid Arthritis and as a Novel Therapeutic Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Antibacterial Flavonoids Against Oral Bacteria of Enterococcus Faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and Its Inhibitor Activity Against Enzyme MurA
Current Drug Discovery Technologies Flexible Estrogen Receptor Modulators: Synthesis, Biochemistry and Molecular Modeling Studies for 3-Benzyl-4,6-diarylhex-3-ene and 3,4,6-Triarylhex-3-ene Derivatives
Medicinal Chemistry GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Editorial (Thematic Issue: Phytochemicals, Intracellular Signalling Pathways and Anti-Cancer Effects)
Anti-Cancer Agents in Medicinal Chemistry Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Intraarticular Treatments for Osteoarthritis: New Perspectives
Current Drug Targets